肝炎常用中藥之現代藥理機轉文獻回顧

A Review of Chinese Herbal Medicines Used for Hepatitis

10.6516/TJTCM.2017.20(1)95

嚴如慶(Ju-Ching Yen)；蔡金川(Chin-Chuan Tsai)

肝炎 ； 中藥 ； Hepatitis ； traditional Chinese medicine

中醫藥研究論叢

20卷1期（2017 / 03 / 30）

95 - 102

繁體中文

台灣的肝炎盛行率非常高，肝炎造成的傷害會變成肝纖維化，而導致肝硬化，中藥常用來治療肝病，因此找尋有效的成分是中醫藥研究的方向，利用天然藥物學、分子生物學的技術，希望能夠從天然藥物中篩選出有效的抗肝炎成分。本文探討常見肝炎治病的中西醫病因，並回顧文獻探討臨床常用治療肝炎中藥之機轉，發現丹參、黃耆、大黃、黃芩等藥物，可以抗肝炎病毒，透過不同的機轉來抑制病毒，如：抑制病毒的複製、控制細胞凋亡、提升免疫力來達到療效，有些藥物尚有改善肝功能、抗肝纖維化等功效。

Taiwan have very high rates of hepatitis and the inflammation and damage can cause fibrosis, which eventually can lead to cirrhosis. Traditional Chinese medicine is commonly used in treating liver diseases. It is important that the challenge to find effective components in traditional chinese medical. By using the technology of natural medicine and molecular biology, the ingredients of natural medicine can be selected in curing heptitis. In this paper, we discuss the common causes of hepatitis treatment in Western and Chinese medicine. Also, we review several research papers about mechanisms of Chinese herbal medicines used in treatment of hepatitis, such as Salvia, Astragalus, rhubarb and skullcap. All of them can be anti-hepatitis virus by different mechanisms to inhibit viral transfer, such as inhibition of viral replication, control apoptosis, boost the immune system to achieve a therapeutic effect,and individually may have the effects of improving liver function, hepatic fibrosis for treating heptitis.

1. (2009)。慢性肝病中西醫結合治療學。人民衛生出版社。
2. (2009)。中西醫結合。萬里出版社。
3. (2000)。肝病中西醫雙效自療手冊。旺文社股份有限公司。
4. (2007)。急慢性肝炎。行政院衛生署中醫藥委員會。
5. (2012)。中醫內科證治學。弘祥出版社。
6. Chen, SR,Chen, XP,Lu, JJ,Wang, Y,Wang, YT.(2015).Potent natural products and herbal medicines for treating liver fibrosis.Chin Med.,15(10),7.
7. Chiang, LC,Ng, LT,Liu, LT,Shieh, DE,Lin, CC.(2003).Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species.Planta Med.,69(8),705-9.
8. Cui, X.,Wang, Y.,Kokudo, N.,Fang, D.,Tang, W.(2010).Traditional Chinese medicine and related active compounds against hepatitis B virus infection.Biosci. Trends,4,39-47.
9. Du, X,Chen, X,Zhao, B,Lv, Y,Zhang, H,Liu, H,Chen, Z,Chen, Y,Zeng, X.(2011).Astragalus polysaccharides enhance the humoral and cellular immune responses of hepatitis B surface antigen vaccination through inhibiting the expression of transforming growth factor β and the frequency of regulatory T cells.FEMS Immunol Med Microbiol.,63(2),228-35.
10. Ghosh, N,Ghosh, R,Mandal, V,Mandal, SC.(2011).Recent advances in herbal medicine for treatment of liver diseases.Pharm Biol.,49(9),970-88.
11. Guo, Q,Zhao, L,You, Q,Yang, Y,Gu, H,Song, G,Lu, N,Xin, J(2007).Anti-hepatitis B virus activity of wogonin in vitro and in vivo.Antiviral Res.,74(1),16-24.
12. Ilyas, U,Katare, DP,Aeri, V,Naseef, PP.(2016).A Review on Hepatoprotective and Immunomodulatory Herbal Plants.Pharmacogn Rev.,10(19),66-70.
13. Kong, L,Li, S,Liao, Q,Zhang, Y,Sun, R,Zhu, X,Zhang, Q,Wang, J,Wu, X,Fang, X,Zhu, Y.(2013).Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity.Antiviral Res.,98(1),44-53.
14. Qi, Fanghua、Wang, Zhixue、Cai, Pingping、Zhao, Lin、Gao, Jianjun、Kokudo, Norihiro、Li, Anyuan、Han, Junqing、Tang, Wei(2013)。Traditional Chinese medicine and related active compounds: A review of their role on hepatitis B virus infection。Drug Discov Ther.，7(6)，212-224。
15. Stacchiotti, A,Li, Volti G,Lavazza, A,Rezzani, R,Rodella, LF(2009).Schisandrin B stimulates a cytoprotective response in rat liver exposed to mercuric chloride.Food Chem Toxicol.,47(11),2834-40.
16. Xue, J,Chen, F,Wang, J,Wu, S,Zheng, M,Zhu, H,Liu, Y,He, J,Chen, Z.(2015).Emodin protects against concanavalin A-induced hepatitis in mice through inhibiting activation of the p38 MAPK-NF-κB signaling pathway.Cell Physiol Biochem.,35(4),1557-70.
17. Yan, X,Jiang, Z,Bi, L,Yang, Y,Chen, W(2015).Salvianolic acid A attenuates TNF-α-and D-GalN-induced ER stress-mediated and mitochondrial-dependent apoptosis by modulating Bax/Bcl-2 ratio and calcium release in hepatocyte LO2 cells.Naunyn Schmiedebergs Arch Pharmacol.,388(8),817-30.
18. Zhang, L,Schuppan, D.(2014).Traditional Chinese Medicine (TCM) for fibrotic liver disease: hope and hype.J Hepatol.,61(1),166-8.
19. Zhang, Y,Shan, L,Hua, Y,Wang, D,Zeng, H,Liu, R,Zhang, W,Hu, Z(2013).Baicalein selectively induces apoptosis in activated lymphocytesand ameliorates concanavalin a-induced hepatitis in mice.PLoS One.,8(7)
20. 王建岩(2011)。慢性肝炎中藥治療療效分析。中醫臨床研究，3(8)，37。
21. 王麗丹(2015)。慢性乙型肝炎中醫証型與臨床診斷。亞太傳統醫藥，11(18)，81-2。
22. 吳龍源、賴慧真、吳文碩、蔡淑鈴、張趙敏、蔡美霞、吳秀惠、楊萬清、彭文煌(2009)。中醫門診肝病患者中藥製劑用藥頻率與形態分析。中國醫學期刊，1(2)，21-33。
23. 李淼、李銘、趙澤華(2009)。肝癌中藥介入治療的應用基礎與臨床研究現狀。北京中醫藥，28(2)，145-7。
24. 楊麗春、李國軍、李冬蓮(2012)。乙型肝炎治療藥物的作用機制及其研究進展。中外醫學研究，10(14)，150-1。
25. 趙軍年(2005)。慢性乙型肝炎中藥的合理選擇與應用。中醫藥學刊，14(3)，55-6。
26. 劉燕、買爾旦‧馬合木提、古麗鮮‧胡加(2005)。抗肝癌中藥研究概況。新疆醫科大學學報，28(7)，686-7。
27. 謝德熾、林恭儀、陳立奇、鄭振鴻(2010)。以中醫輔助慢性B 型肝炎治療—是否有進行大型臨床試驗之價值？。內科學誌，21，243-51。